Ovarian cancer treatment faces challenges with high relapse and drug resistance rates, despite initial chemotherapy effectiveness. Cytokines like IL-6 and IL-11 are associated with complex tumor ...

Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative ...

Researchers from the People's Friendship University of Russia (RUDN University) have studied the mechanism of drug resistance for ovarian and breast cancer cells. They discovered that these cancer ...

Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...

The Smolka Lab, led by Prof. Marcus Smolka, molecular biology and genetics, recently published a study shedding light on a novel pathway that explains how cancer cells can become resistant to ...

The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.

TAMPA, Fla. — Leptomeningeal disease is a rare but lethal complication faced by late-stage melanoma patients. It occurs when cancer cells spread to the membranes covering the brain and spinal cord, or ...

Biologists have uncovered a new mode of communication inside cells that helps bacterial pathogens learn how to evade drugs.

FPI-2119 offers potential solution to multi-drug-resistant Gram-negative infectionsEDMONTON, Alberta , Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of ...

In a field that has struggled for decades to keep pace with drug‑resistant infections, researchers have uncovered an antibiotic that hits some of the world’s most dangerous bacteria with roughly 100 ...